Caribou Biosciences, Inc. (CRBU) Financials

CRBU Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 406.8 million 63.5 million
2023-12-31 441.0 million 72.6 million
2023-09-30 457.5 million 59.3 million
2023-06-30 349.6 million 80.2 million

CRBU Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -38.7 million 4.0 million
2023-12-31 -23.7 million 3.6 million
2023-09-30 -33.5 million 3.5 million
2023-06-30 -17.7 million 3.6 million

CRBU Net Income

No data available :(

CRBU Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 294.0 million - 27.2 million
2023-12-31 328.8 million - 27.1 million
2023-09-30 338.5 million - 27.5 million
2023-06-30 292.5 million - 27.2 million

CRBU Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 89.3 million
2023-12-31 88.4 million
2023-09-30 83.8 million
2023-06-30 61.4 million

CRBU Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 1.4 million 33.8 million 14.6 million -
2023-12-31 2.3 million 31.3 million 9.7 million 2.0 million
2023-09-30 4.8 million 28.6 million 9.7 million -
2023-06-30 2.6 million 26.5 million 10.1 million -

CRBU Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 2.4 million 710000
2023-12-31 3.6 million 2.0 million
2023-09-30 23.7 million 2.1 million
2023-06-30 3.8 million 1.1 million

CRBU

Price: $2.85

52 week price:
2.85
8.59

Earnings Per Share: -1.38 USD

P/E Ratio: -4.81

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 355500

Market Capitalization: 319.7 million

Links: